Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04212455

A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)

Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Guangdong Cardiovascular Institute, Guangzhou, Guangdong, China

Loading trial locations.

About this study

Study population includes subjects who are hypertension, of any race or ethnicity, 18 or older years of age, and have provided written informed consent to provide whole blood specimens at one or more study visits.

Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of all-cause and cardiovascular mortality will be investigated during follow-up.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥18 years old
  • In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension)

Exclusion criteria

  • <18 years old
  • Unsigned informed consent
  • Pregnant Women and Lactation

Treatment and study plan

Non-Interventional Study

Other

This is an observational, non-interventional study

Primary outcomes

  1. All-Cause Mortality

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year

    All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Guangdong Provincial Center for Disease Control and Prevention.

Secondary outcomes

  1. Cardiovascular Mortality

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 1 year

    Cardiovascular mortality was defined as death attributable to an ischemic cardiovascular cause (including fatal MI, stroke).

Other outcomes

  1. Secondary outcomes of cardiovascular diseases

    Time frame: Through study completion, an average of 1 years

    The number of and the incidence rate of cardiovascular diseases.

  2. Secondary outcomes of cerebrovascular diseases

    Time frame: Through study completion, an average of 1 years

    The incidence rate of cerebrovascular diseases.

  3. Secondary outcomes of kidney

    Time frame: Through study completion, an average of 1 years

    The incidence rate of hypertensive renal injure and end-stage renal disease

  4. others

    Time frame: From date of inclusion until the date of first event, assessed up to 1 year

    Number of participants with reported hospitalization due to other diseases(eg. diabetes， tumor)

Study contacts

Contact information is provided by the study sponsor or research team.

Feng Ying-qing, PhD

CONTACT

[email protected]

86-2083827812

HUANG Yu qing, MD

CONTACT

[email protected]

+8613172054256

Sponsors and collaborators

Lead sponsor

Guangdong Provincial People's Hospital

Other

Registry information

Official study title

Establishing Biobank in a Cohort Study for Hypertensive Patients in Guangdong Province(GDP Study)

Important dates

Study start
2020
Primary completion
2022
Study completion
2050
First posted
Dec 27, 2019
Registry last updated
Jan 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.